Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial

Open access
Raeissadat, Seyed Ahmad, Rayegani, Seyed Mansoor, Ahangar, Azadeh Gharooee, Abadi, Porya Hassan, Mojgani, Parviz, Ahangar, Omid Gharooi · 2017 · Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Abstract

Background and objectives: Knee osteoarthritis is the most common joint disease. We aimed to compare the efficacy and safety of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid (HA) on pain and function of patients with knee osteoarthritis. Methods: In this single-blinded randomized clinical trial, patients with symptomatic osteoarthritis of knee were assigned to receive 2 intra-articular injections of our newly developed PRGF in 3 weeks or 3 weekly injections of HA. Our primary outcome was the mean change from baseline until 2 and 6 months post intervention in scores of visual analog scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index. We used analysis of variance for repeated-measures statistical test. Results: A total of 69 patients entered final analysis. The mean age of patients was 58.2 ± 7.41 years and 81.2% were women. In particular, total WOMAC index decreased from 42.9 ± 13.51 to 26.8 ± 13.45 and 24.4 ± 16.54 at 2 and 6 months in the newly developed PRGF group (within subjects P = .001), and from 38.8 ± 12.62 to 27.8 ± 11.01 and 27.4 ± 11.38 at 2 and 6 months in the HA group (within subjects P = .001), respectively (between subjects P = .631). There was no significant difference between PRGF and HA groups in patients’ satisfaction and minor complications of injection, whereas patients in HA group reported significantly lower injection-induced pain. Conclusions: In 6 months follow up, our newly developed PRGF and HA, both are effective options to decrease pain and improvement of function in patients with symptomatic mild to moderate knee osteoarthritis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1179544117733452

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Enrollment and allocation diagram.
Figure 1. Enrollment and allocation diagram.CC BY-NC · PubMed Central
Figure 2. Means of VAS at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor; VAS, visual analog scale.
Figure 2. Means of VAS at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor; VAS, visual analog scale.CC BY-NC · PubMed Central
Figure 3. Means of WOMAC total scores at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Figure 3. Means of WOMAC total scores at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.CC BY-NC · PubMed Central
Figure 4. Mean values of Lequesne total at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor.
Figure 4. Mean values of Lequesne total at baseline and 2 and 6 months after injection. PRGF indicates plasma rich in growth factor.CC BY-NC · PubMed Central
Figure 5. Mean Lequesne index scores at baseline and 2 and 6 months postinjection in PRGF and HA groups. (a) pain subscale, (b) maximum walking subscale, and (c) activities of daily life subscale. Blue: PRGF, green: HA. 95% CI indicates 95% confidence interval; HA, hyaluronic acid; PRGF, plasma rich in growth factor.
Figure 5. Mean Lequesne index scores at baseline and 2 and 6 months postinjection in PRGF and HA groups. (a) pain subscale, (b) maximum walking subscale, and (c) activities of daily life subscale. Blue: PRGF, green: HA. 95% CI indicates 95% confidence interval; HA, hyaluronic acid; PRGF, plasma rich in growth factor.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. 10.1517/14712598.2013.801450 · DOI

Cited by

See all 76

Metadata

Authors
Raeissadat, S. A., Rayegani, S. M., Ahangar, A. G., Abadi, P. H., Mojgani, P., & Ahangar, O. G.
Affiliations
  • Shahid Beheshti University (IR)
  • University of Birmingham (GB)
  • Rehabilitation and Medical Education Department, Iran Helal institute of Applied Sciences and Technology, affiliated to the Red Crescent Society of Iran, Tehran, Iran
Corresponding author
Ahangar, Azadeh Gharooee
Venue
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Published
2017-01
Volume
10
Pages
1179544117733452-1179544117733452
ISSN
  • 1178-1149 (ISSN-L)
  • 1179-5441
OpenAlex
W2761873219
Cited by
70
References
45
Citations by year
2026: 3 · 2025: 8 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 17 · 2019: 7 · 2018: 6
FWCI
11.48
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
Keywords
knee osteoarthritis, plasma rich in growth factors, hyaluronic acid, intra-articular injection, pain, functional outcome, WOMAC index, Lequesne index, injection complications, patient satisfaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial. https://app.cochat.ai/papers/10.1177/1179544117733452
The paper
Raeissadat, S. A., Rayegani, S. M., Ahangar, A. G., Abadi, P. H., Mojgani, P., & Ahangar, O. G. (2017). Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. https://doi.org/10.1177/1179544117733452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.